Loading...
Please wait, while we are loading the content...
Similar Documents
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma
| Content Provider | Scilit |
|---|---|
| Author | Picardi, M. Pepa, R. Della Giordano, C. Pugliese, N. Mortaruolo, C. Trastulli, F. Rascato, M. G. Cappuccio, I. Raimondo, M. Memoli, M. Monteverde, M. Mascolo, M. Pane, F. |
| Copyright Year | 2019 |
| Description | Key Points FDG-PET–negative status achieved with salvage therapy is the most important determinant of favorable outcome after HSCT, for patients with R/R cHL. Our modified Bv+Bs salvage regimen led to deep metabolic responses in the majority of patients, establishing a bridge to transplant. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517654/pdf |
| Ending Page | 1552 |
| Page Count | 7 |
| Starting Page | 1546 |
| DOI | 10.1182/bloodadvances.2019000123 |
| Journal | Blood advances |
| Issue Number | 9 |
| Volume Number | 3 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2019-05-14 |
| Access Restriction | Open |
| Subject Keyword | Hematology Treatment Survival Hematopoietic Prophylaxis Pfs Deep Metabolic Response Journal: Blood advances (Vol- 106, Issue- 9) |
| Content Type | Text |
| Resource Type | Article |